Skip to main content
← Back to home

Accessibility Statement

Last updated: July 24, 2026 · Rejuven website

Rejuven is committed to making this website usable by as many people as possible, including people with disabilities. We aim to conform to the Web Content Accessibility Guidelines (WCAG) 2.2 Level AA and applicable ADA-related digital accessibility expectations.

Measures we take

  • Semantic structure and a main content landmark for assistive technologies
  • Skip to main content link for keyboard users
  • Visible focus indicators on interactive controls
  • Document language set to English (lang="en")
  • Responsive, mobile-first layout with readable type and touch-friendly targets where practical (≈44×44px)
  • Images: meaningful alt text where content-bearing; decorative images marked appropriately
  • Cookie consent dialog: keyboard operable, screen-reader labels, focus management, no keyboard trap outside intended modal behavior
  • Respect for prefers-reduced-motion and improved contrast preferences where supported
  • Meta viewport configured for mobile devices without disabling user zoom

Mobile optimization

  • Layouts adapt across phone, tablet, and desktop breakpoints
  • Horizontal overflow is constrained; media scales within the viewport
  • Form controls use font sizes that reduce unwanted mobile zoom on focus
  • Safe-area padding considered for notched devices on key UI (e.g. consent banner)

Known limitations

We continue to improve contrast, labeling, and keyboard paths as we iterate. Some third-party fonts or complex interactive components may not yet meet every AA criterion in every browser.

How we test

  • Keyboard-only navigation (Tab / Shift+Tab / Enter / Escape)
  • Screen reader spot checks (VoiceOver / NVDA where available)
  • Browser zoom to 200%
  • Recommended tools: Lighthouse Accessibility, axe DevTools, WAVE

Feedback

If you encounter an accessibility barrier, please contact Admin@myrejuven.com with the page URL and a description of the issue. We will work to provide information in an accessible format and improve the site.

Related: Cookie Policy · Cookie Settings · Privacy Policy

FDA DISCLAIMER

Statements made regarding our products have not been evaluated by the U.S. Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. Products are not intended to diagnose, treat, cure, or prevent any disease. Information presented on this website is not a substitute for, or alternative to, information from a qualified health care practitioner. Please consult a licensed health care professional regarding any potential interactions or complications before using any product. This notice is required under the Federal Food, Drug, and Cosmetic Act.

© 2026 Rejuven all rights reserved · sold for research and laboratory use only